Casein kinase 1α interacts with RIP1 and regulates NF-κB activation

Biochemistry

Volumn 47, Issue 1, 2008, Pages 441-448

  Wang, Yong ^a   Sun, Xiaoqing ^b,d   Wu, Jun ^b,d,e   Xu, Bing E ^d   Gu, Cuiping ^d   Wang, Hui ^c   Wang, Xin ^a,b   Tan, Fengwei ^a   Peng, Xiaozhong ^a   Qiang, Boqin ^a,b   Yuan, Jiangang ^a   Luo, Ying ^b,d,e  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^c FUJIAN NORMAL UNIVERSITY   (China)

^d Shanghai Genomics Inc   (China)

^e GNI Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE; KINASE DEAD MUTANTS; PATHOLOGICAL PROCESSES;

GENETIC ENGINEERING; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ENZYMES;

CASEIN KINASE IALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; MUTANT PROTEIN; RECEPTOR INTERACTING PROTEIN 1; RECEPTOR INTERACTING PROTEIN 140; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; CASEIN KINASE I; HRB PROTEIN, HUMAN; NUCLEOPORIN; RNA BINDING PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAMMAL CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; CELL LINE; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HELA CELL; IMMUNOPRECIPITATION; METABOLISM; PROTEIN BINDING; WESTERN BLOTTING;

MAMMALIA;

BLOTTING, WESTERN; CASEIN KINASE I; CELL LINE; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; NF-KAPPA B; NUCLEAR PORE COMPLEX PROTEINS; PROTEIN BINDING; RNA-BINDING PROTEINS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37849016617     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi7010515     Document Type: Article

References (31)

1. Chen, G., and Goeddel, D. V. (2002) TNF-R1 signaling: a beautiful pathway, Science 296, 1634-1635.
2. Karin, M., and Lin, A. (2002) NF-kappaB at the crossroads of life and death, Nat. Immunol. 3, 221-227.
3. Bouwmeester, T., Bauch, A., Ruffner, H., Angrand, P. O., Bergamini, G., Croughton, K., Cruciat, C., Eberhard, D., Gagneur, J., Ghidelli, S., Hopf, C., Huhse, B., Mangano, R., Michon, A. M., Schirle, M., Schlegl, J., Schwab, M., Stein, M. A., Bauer, A., Casari, G., Drewes, G., Gavin, A. C., Jackson, D. B., Joberty, G., Neubauer, G., Rick, J., Kuster, B., and Superti-Furga, G. (2004) A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway, Nat. Cell Biol. 6, 97-105.
4. Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z., and Leder, P. (1998) The death domain kinase RIP mediates the TNF-induced NF-kappaB signal, Immunity 8, 297-303.
5. Sun, X., Yin, J., Starovasnik, M. A., Fairbrother, W. J., and Dixit, V. M. (2002) Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3, J. Biol. Chem. 277, 9505-9511.
6. Yu, P. W., Huang, B. C., Shen, M., Quast, J., Chan, E., Xu, X., Nolan, G. P., Payan, D. G., and Luo, Y. (1999) Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB, Curr. Biol. 9, 539-542.
7. Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., Ma, A., Koonin, E. V., and Dixit, V. M. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling, Nature 430, 694-699.
8. Heyninck, K., and Beyaert, R. (2005) A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions, Trends Biochem. Sci. 30, 1-4.
9. Kanayama, A., Seth, R. B., Sun, L., Ea, C. K., Hong, M., Shaito, A., Chiu, Y. H., Deng, L., and Chen, Z. J. (2004) TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains, Mol. Cell 15, 535-548.
10. Gao, Z. H., Seeling, J. M., Hill, V., Yochum, A., and Virshup, D. M. (2002) Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex, Proc. Natl. Acad. Sci. U.S.A. 99, 1182-1187.
11. Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., Zhang, Z., Lin, X., and He, X. (2002) Control of beta-catenin phosphorylation/ degradation by a dual-kinase mechanism, Cell 108, 837-847.
12. Knippschild, U., Gocht, A., Wolff, S., Huber, N., Lohler, J., and Stoter, M. (2005) The casein kinase 1 family: participation in multiple cellular processes in eukaryotes, Cell Signal 17, 675-689.
13. Cong, F., Schweizer, L., and Varmus, H. (2004) Casein kinase Iepsilon modulates the signaling specificities of dishevelled, Mol. Cell. Biol. 24, 2000-2011.
14. Zhu, J., Shibasaki, F., Price, R., Guillemot, J. C., Yano, T., Dotsch, V., Wagner, G., Ferrara, P., and McKeon, F. (1998) Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1, Cell 93, 851-861.
15. Okamura, H., Garcia-Rodriguez, C., Martinson, H., Qin, J., Virshup, D. M., and Rao, A. (2004) A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1, Mol. Cell. Biol. 24, 4184-4195.
16. Zhang, C., Williams, E. H., Guo, Y., Lum, L., and Beachy, P. A. (2004) Extensive phosphorylation of Smoothened in Hedgehog pathway activation, Proc. Natl. Acad. Sci. U.S.A. 101, 17900-17907.
17. Jia, J., Tong, C., Wang, B., Luo, L., and Jiang, J. (2004) Hedgehog signalling activity of Smoothened requires phosphorylation by protein kinase A and casein kinase I, Nature 432, 1045-1050.
18. Waddell, D. S., Liberati, N. T., Guo, X., Frederick, J. P., and Wang, X. F. (2004) Casein kinase Iepsilon plays a functional role in the transforming growth factor-beta signaling pathway, J. Biol. Chem. 279, 29236-29246.
19. Izeradjene, K., Douglas, L., Delaney, A. B., and Houghton, J. A. (2004) Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex, Cancer Res. 64, 8036-8044.
20. Desagher, S., Osen-Sand, A., Montessuit, S., Magnenat, E., Vilbois, F., Hochmann, A., Journot, L., Antonsson, B., and Martinou, J. C. (2001) Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8, Mol. Cell 8, 601-611.
21. Beyaert, R., Vanhaesebroeck, B., Declercq, W., Van Lint, J., Vandenabele, P., Agostinis, P., Vandenheede, J. R., and Fiers, W. (1995) Casein kinase-1 phosphorylates the p75 tumor necrosis factor receptor and negatively regulates tumor necrosis factor signaling for apoptosis, J. Biol. Chem. 270, 23293-23299.
22. McFarlane, S. M., Pashmi, G., Connell, M. C., Littlejohn, A. F., Tucker, S. J., Vandenabeele, P., and MacEwan, D. J. (2002) Differential activation of nuclear factor-kappaB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly, FEBS Lett. 515, 119-126.
23. Meylan, E., and Tschopp, J. (2005) The RIP kinases: crucial integrators of cellular stress, Trends Biochem. Sci. 30, 151-159.
24. Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J. L., Schneider, P., Seed, B., and Tschopp, J. (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule, Nat. Immunol. 1, 489-495.
25. Watts, A. D., Hunt, N. H., Wanigasekara, Y., Bloomfield, G., Wallach, D., Roufogalis, B. D., and Chaudhri, G. (1999) A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling', EMBO J. 18, 2119-2126.
26. Alappat, E. C., Feig, C., Boyerinas, B., Volkland, J., Samuels, M., Murmann, A. E., Thorburn, A., Kidd, V. J., Slaughter, C. A., Osborn, S. L., Winoto, A., Tang, W. J., and Peter, M. E. (2005) Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities, Mol. Cell 19, 321-332.
27. Legier, D. F., Micheau, O., Doucey, M. A., Tschopp, J., and Bron, C. (2003) Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation, Immunity 18, 655-664.
28. Li, H., Kobayashi, M., Blonska, M., You, Y., and Lin, X. (2006) Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation, J. Biol. Chem. 281, 13636-13643.
29. Lewis, J., Devin, A., Miller, A., Lin, Y., Rodriguez, Y., Neckers, L., and Liu, Z. G. (2000) Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation, J. Biol. Chem. 275, 10519-10526.
30. Lee, T. H., Shank, J., Cusson, N., and Kelliher, M. A. (2004) The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2, J. Biol. Chem. 279, 33185-33191.
31. Chen, G., Bhojani, M. S., Heaford, A. C., Chang, D. C., Laxman, B., Thomas, D. G., Griffin, L. B., Yu, J., Coppola, J. M., Giordano, T. J., Lin, L., Adams, D., Orringer, M. B., Ross, B. D., Beer, D. G., and Rehemtulla, A. (2005) Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas, Proc. Natl. Acad. Sci. U.S.A. 102, 12507-12512.